Browsing by Author Zang, Dae Young
Showing results 1 to 10 of 10
Showing results 1 to 10 of 10
|Issue Date||Title / Author(s) / Citation||File||Altmetrics|
Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer
Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study
Incidence and Biologic Features of 5q Deletion and 5q-Syndrome in Myelodysplastic Syndrome in Korea; According to Reclassification of Myelodysplastic Syndrome by WHO 2008.
Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML.
Moon, Joon Ho; Sohn, Sang Kyun; Lee, Soo Jung; Lee, Yoo Jin; Kim, Hyeoung Joon; Joo, Young Don; Kim, Dung Hwan; Kim, Min Kyoung; Park, Seonyang; Park, Eun Kyung; Eom, Ki-Seong; Ryoo, Hui-Mo; Cheong, June-Won; Min, Yoo-Hong; Park, Jinny; Kim, Hawk; Park, Joon Seong; Kim, Inho; Won, Jong Ho; Jo, Deog Yeon; Lee, Hong Ghi; Bang, Soo-Mee; Zang, Dae Young; Kim, Chul Soo; Kim, Byung Soo; Oh, Suk-Joong; Park, Moo Rim; Chung, Jooseop; Hyun, Myung Soo; Jung, Chul Won; Kim, Yeo Kyeoung; Do, Young Rok
BLOOD; Vol.116 21; 935-935
Bone Marrow Cellularity Is a Single Most Important Independent Prognostic Factor In AML Patients with t(8;21).
Shin, Ho-Jin; Chung, Jooseop; Kim, Hyeoung Joon; Sohn, Sang Kyun; Won, Jong-Ho; Kim, Inho; Choi, Seong-Jun; Yoon, Hwi-Joong; Kim, Seok Jin; Bang, Soo-Mee; Lee, Junglim; Kim, Sun-Hee; Ahn, Jin Seok; Jung, Chul W.; Zang, Dae Young; Hong, Dae Sik; Joo, Young Don; Jo, Deog Yeon; Lee, Kyoo Hyung; Lee, Jae Hoon; Lee, Jung-Hee; Lee, Je-Hwan; Bae, Sung Hwa; Min, Yoo-Hong
BLOOD; Vol.116 21; 715-715
Cytogenetic features of 5q deletion and 5q-syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization
Lee, Hye Ryun; Oh, Bora; Hong, Dae Sik; Zang, Dae Young; Kim, Hyeoung Joon; Ahn, Jae-Sook; Lee, Kyung-A; Lee, Mark Hong; Kim, Tae Young; Lee, You Kyoung; Min, Yoo Hong; Yun, Yeo-Min; Bang, Soo-Mee; Cho, Kyung Sam; Cheong, June-Won; Kim, Inho; Yoon, Hwi-Joong; Lee, Dong Soon
CANCER GENETICS AND CYTOGENETICS; Vol.203 2; 193-202
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research
Phase I/II study of weekly Oraxol for the second-line treatment of patients with metastatic or recurrent gastric cancer
Randomized, double-blind phase II trial with prospective classification by ATM protein level to evaluate the efficacy and tolerability of olaparib plus paclitaxel in patients with recurrent or metastatic gastric cancer
Bang, Yung-Jue; Im, Seock-Ah; Lee, Keun-Wook; Cho, Jae Yong; Song, Eun-Kee; Lee, Kyung Hee; Kim, Yeul Hong; Park, Joon Oh; Chun, Hoo Geun; Zang, Dae Young; Fielding, Anitra; Rowbottom, Jacqui; Hodgson, Darren; O'Connor, Mark J.; Yin, Xiaolu; Kim, Woo Ho]
Journal of Clinical Oncology, Vol.33 No.33, pp.3858-3865
A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer